Everything you need to know about ADA 2025
Check out Breakthrough T1D's ADA 2025 coverage of cutting-edge T1D updates in cures, improving lives, and clinical adoption.
ADA 2025 Recap: Medical Affairs
Medical Affairs Breakthrough T1D’s Medical Affairs program is bridging the gap between access to and adoption of therapies, treatments, drugs,…
ADA 2025 Recap: Cures
Breakthrough T1D was in Chicago, IL for ADA 2025. Here we report on the latest advancements in cures for type…
ADA 2025 Recap: Improving Lives
Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to…
Breakthrough T1D heads to ADA’s 85th Scientific Sessions
Breakthrough T1D is heading to Chicago, IL to attend the 2025 ADA conference from June 20-23 to discuss cutting-edge type…
Breakthrough T1D helps organize an event at the European Parliament about unmet needs for T1D and accelerating cures
This meeting focused on the role of the EU in addressing the needs of the T1D community and accelerating T1D…
Medical Affairs team kicks off international islet cell therapy workshops at Breakthrough T1D HQ
Breakthrough T1D's Medical Affairs team hosted experts in islet transplantation to discuss a clinical roadmap for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key…
Riding coast to coast for cures
Matt Varey, a key volunteer with Breakthrough T1D, will embark on a two-month-long, 7,500 km cycling journey across Canada to…
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
